SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-15-011560
Filing Date
2015-12-18
Accepted
2015-12-18 09:00:28
Documents
3
Period of Report
2015-12-14
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K atrs-8k_20151214.htm 8-K 30805
2 EX-99.1 PRESS RELEASE DATED DECEMBER 14, 2105 atrs-ex991_7.htm EX-99.1 23463
3 GRAPHIC g201512172218396503205.jpg GRAPHIC 17898
  Complete submission text file 0001564590-15-011560.txt   80491
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 151295339
SIC: 3841 Surgical & Medical Instruments & Apparatus